Positron emission tomography-based boron neutron capture therapy using boronophenylalanine for high-grade gliomas: Part II

Clinical Cancer Research

Volumn 4, Issue 8, 1998, Pages 1833-1841

  Imahori, Yoshio ^a   Ueda, Satoshi ^a   Ohmori, Yoshio ^a   Sakae, Kenji ^a   Kusuki, Tsukasa ^a   Kobayashi, Tooru ^b   Takagaki, Masao ^b   Ono, Koji ^b   Ido, Tatsuo ^c   Fujii, Ryou ^d  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c TOHOKU UNIVERSITY   (Japan)

^d Nishijin Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BORON 10; BORON DERIVATIVE; FLUORINE 18; PHENYLALANINE DERIVATIVE;

ARTICLE; CANCER DIAGNOSIS; CANCER GRADING; CANCER RADIOTHERAPY; CANCER SURGERY; CLINICAL ARTICLE; GLIOMA; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; NEUTRON CAPTURE THERAPY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

BORON; BORON COMPOUNDS; BORON NEUTRON CAPTURE THERAPY; FLUORINE RADIOISOTOPES; GLIOMA; HUMANS; ISOTOPES; MATHEMATICAL COMPUTING; PHENYLALANINE; RADIATION-SENSITIZING AGENTS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0031824582     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Sweet, W. H. Early history of development of boron neutron capture therapy of tumors. J. Neuro-Oncol., 33: 19-26, 1997.
2. Asbury, A. K., Ojemann, R. G., Nielsen, S. L., and Sweet, W. H. Neuropathologic study of fourteen cases of malignant brain tumor treated by boron-10 slow neutron capture radiation. J. Neuropathol. Exp. Neurol., 31: 278-303, 1972.
3. Hatanaka, H. Experience of boron neutron capture therapy for malignant brain tumors with special reference to the problems of postoperative CT follow-ups. Acta Neurochir. Suppl., 42: 187-192, 1988.
4. Barth, R. F., Soloway, A. H., and Fairchild, R. G. Boron neutron capture therapy of cancer. Cancer Res., 50: 1061-1070, 1990.
5. Soloway, A. H., Barth, R. F., Gahbauer, R. A., Blue, T. E., and Goodman, J. H. The rationale and requirements for the development of boron neutron capture therapy of brain tumors. J. Neuro-Oncol., 33: 9-18, 1997.
6. Imahori, Y., Ueda, S., Ohmori, Y., Sakae, K., Kusuki, T., Kobayashi, T., Takagaki, M., Ono, K., Ido, T., and Fujii, R. Positron emission tomography-based boron neutron capture therapy using boronophenylalanine for high-grade gliomas: part I. Clin. Cancer Res., 4: 1825-1832, 1998.
7. 18F-DOPA analogue. J. Neuro-Oncol., 33: 163-169, 1997.
8. Imahori, Y., Ueda, S., Ohmori, Y., Yoshino, E., Ono, K., Kobayashi, T., Ido, T., and Mishima, Y. A basic concept for PET-BNCT system. In: Y. Mishima (ed.), Cancer Neutron Capture Therapy, pp. 691-696. New York: Plenum Press, 1996.
9. Imahori, Y., Ueda, S., Ohmori, Y., Kusuki, T., Ono, K., Fujii, R., and Ido, T. Fluorine-18-labeled fluoroboronophenylalanine and PET in patients with glioma. J. Nucl. Med., 39: 325-333, 1998.
10. Yoshino, K., Suzuki, A., Mori, Y., Kakihana, H., Honda, C., Mishima, Y., Kobayashi, T., and Kanda, K. Improvement of solubility of p-boronophenylalanine by complex formation with monosaccharides. Strahlenther. Onkol., 165: 127-129, 1989.
11. Kakihana, H., Yoshino, K., and Mori, Y. Relation between structures of p-boronophenylalanine related compounds and their usefulness for boron neutron capture therapy. In: A. H. Soloway et al. (eds.), Advances in Neutron Capture Therapy, pp. 257-260. New York: Plenum Press, 1993.
12. Phelps, M. E., Huang, S-C., Hoffman, E. J., and Kuhl, D. E. Validation of tomographic measurement of cerebral blood volume with C-11-labeled carboxyhemoglobin. J. Nucl. Med., 20: 328-334, 1979.
13. 18F]fluoro-D,L-phenylalanine as a target compound for boron neutron capture therapy: tumor imaging potential with positron emission tomography. Nucl. Med. Biol., 18: 745-751, 1991.
14. Gjedde, A. High- and low-affinity transport of D-glucose from blood to brain. J. Neurochem., 36: 1463-1471, 1981.
15. Patlak, C. S., Blasberg, R. G., and Fenstmacher, J. D. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J. Cereb. Blood Flow Metab., 3: 1-7, 1983.
16. 18F)fluorotyrosine. J. Nucl. Med., 32: 1338-1346, 1991.
17. Coenen, H. H., Kling, P., and Stöcklin, G. Cerebral metabolism of L-[2-18F]fluorotyrosine, a new PET tracer of protein synthesis. J. Nucl. Med., 30: 1367-1372, 1989.
18. 11C]-tyrosine and PET. J. Nucl. Med., 36: 411-419, 1995.
19. Keen, R. E., Barrio, J. R., Huang, S-C., Hawkins, R. A., and Phelps, M. E. In vivo cerebral protein synthesis rates with leucyl-transfer RNA used as a precursor pool: determination of biochemical parameters to structure tracer kinetics models for positron emission tomography. J. Cereb. Blood Flow Metab., 9: 429-445, 1989.
20. Huang, S-C., Phelps, M. E., Hoffmann, E. J., Sideris, K., Selin, C. J., and Kuhl, D. E. Non-invasive determination of local cerebral metabolic rate of glucose in man. Am. J. Physiol., 238: E69-E82, 1980.
21. Laramore, G. E., and Spence, A. M. Boron neutron capture therapy (BNCT) for high-grade gliomas of the brain: a cautionary note. Int. J. Radiat. Oncol. Biol. Phys., 36: 241-246, 1996.
22. Kabalka, G. W., Smith, G. T., Dyke, J. P., Reid, W. S., Longford, C. P. D., Roberts, T. G., Reddy, N. K., and Hübner, K. F. Evaluation of fluorine-18-BPA-fructose for boron neutron capture treatment planning. J. Nucl. Med., 38: 1762-1767, 1997.
23. Elowitz, E. H., Bergland, R. M., Coderre, J. A., Joel, D. D., Chadha, M., and Chanana, A. D. Biodistribution of p-boronophenylalanine in patients with glioblastoma multiforme for use in boron neutron capture therapy. Neurosurgery (Baltimore), 42: 463-469, 1998.
24. 10B-BPA. In: Y. Mishima (ed.), Cancer Neutron Capture Therapy, pp. 823-827. New York: Plenum Press, 1996.
25. Ueda, S., Imahori, Y., Ohmori, Y., Kusuki, T., Yoshino, E., Takagaki, M., Kobayashi, T., Ono, K., Fujii, R., and Ido, T. Positron emission tomography boron neutron capture therapy system and clinical application to patients with malignant glioma. In: B. Larsson, J. Crawford, and R. Weinreich (eds.), Advances in Neutron Capture Therapy, Vol. II, Chemistry and Biology, pp. 280-285. Amsterdam: Elsevier Science Publishers, B. V., 1997.